Hexagon Bio
Hexagon Bio is hiring a Scientist I/II to join its Protein Science team in Menlo Park, CA. The laboratory-based role supports the company’s ADC pipeline by focusing on conjugation, purification, and analytical characterization of antibody–drug conjugates using natural-product–based payloads. The position contributes materials for in vitro and in vivo studies within a fast-paced startup environment.
Hexagon Bio is a biotechnology company focused on developing novel payload mechanisms for antibody-drug conjugates (ADCs) to treat cancer. The company aims to overcome resistance to existing ADC payloads and expand ADC indications through its pipeline and scientific platform. Hexagon Bio operates in the biotech and oncology therapeutics industry.
Wilson Sonsini Advises Hexagon Bio on Multimillion-Dollar Joint Venture with Corteva
Dec 17, 2025
Corteva, Hexagon Bio Form Multi-Million Dollar JV to Power Next-Generation of Nature Inspired Solutions
Dec 16, 2025
Corteva, Hexagon Bio launch joint venture to develop crop protection
Dec 16, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Hexagon Bio.
Hexagon Bio & Corteva Form JV to Advance Nature-Inspired Crop Protection
Dec 17, 2025
Senior Scientist, Protein and Antibody Bioconjugation
lifelancer
Senior Scientist II, ADC/AOC Conjugation
AbbVie
Senior Scientist I, ADC/AOC Conjugation
AbbVie
Sr. Scientist, Protein and Antibody Bioconjugation
Neurocrine Biosciences
Associate Scientist Ii Conjugation Chemistry United States
alnylam
Senior Scientist II, ADC/AOC Conjugation
AbbVie